FDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Breakthrough DLL3-Targeting Therapy Regimen for a Major Solid Tumor
Source: kpvi.com
📰 Targeting Therapy News
Targeting Therapy News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Targeting Therapy. Real-time updates on events, politics, business and more.
FDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER
/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved IMDELLTRA™ (tarlatamab-dlle) for the...
Source: prnewswire.com
A little girl's legacy: Edenfield family's $150K donation creates new ACH fund | News, Sports, Jobs
Familyâs $150K donation creates new ACH fund Mar 15, 2021 A close-knit trio were Emilea, Melina and Klara Edenfield. After Melina lost her battle with a brain tumor, the two remaining sisters felt a void in their lives. Submitted photo CANFIELD — Melina Michelle Edenfield was an energetic 4-year-old Canfield girl who on May 22, 2020, was diagnosed with a deadly brain tumor. Her fight with diffuse midline glioma ended just 32 days later. While her battle was brief, her family wanted to ...
Source: vindy.com